Effects of steroids on reintubation and post-extubation stridor in adults: meta-analysis of randomised controlled trials

Samir Jaber, Boris Jung, Gérald Chanques, Francis Bonnet, Emmanuel Marret, Samir Jaber, Boris Jung, Gérald Chanques, Francis Bonnet, Emmanuel Marret

Abstract

Introduction: The efficacy of steroid administration before planned tracheal extubation in critical care patients remains controversial with respect to the selection of patients most likely to benefit from this treatment.

Methods: We performed an extensive literature search for adult trials testing steroids versus placebo to prevent reintubation or laryngeal dyspnoea. Studies were evaluated on a five-point scale based on randomisation, double-blinding and follow-up. Our analysis included trials having a score three or higher with patients mechanically ventilated for at least 24 hours and treated with steroids before extubation, taking into account the time of their administration (early vs late) and if the population selected was at risk or not.

Results: Seven prospective, randomised, double-blinded trials, including 1846 patients, (949 of which received steroids) were selected. Overall, steroids significantly decreased the risk of reintubation (relative risk (RR) = 0.58, 95% confidence interval (CI) = 0.41 to 0.81; number-needed-to-treat (NNT) = 28, 95% CI = 20 to 61) and stridor (RR = 0.48, 95% CI = 0.26 to 0.87; NNT = 11, 95% CI = 8 to 42). The effect of steroids on reintubation and stridor was more pronounced for selected high-risk patients, as determined by a reduced cuff leak volume (RR = 0.38, 95% CI = 0.21 to 0.72; NNT = 9, 95% CI = 7 to 19; and RR = 0.40, 95% CI = 0.25 to 0.63; NNT = 5, 95% CI = 4 to 8, respectively). In contrast, steroid benefit was unclear when trials did not select patients for their risk of reintubation (RR = 0.67, 95% CI = 0.45 to 1.00; NNT = 44, 95% CI >/= 26 to infinity) or stridor (RR = 0.56, 95% CI = 0.20 to 1.55).

Conclusions: The efficacy of steroids to prevent stridor and reintubation was only observed in a high-risk population, as identified by the cuff-leak test and when it was administered at least four hours before extubation. The benefit of steroids remains unclear when patients at high risk are not selected.

Figures

Figure 1
Figure 1
Flowchart of randomised controlled trials selected for the meta-analysis. ARDS = acute respiratory distress syndrome.
Figure 2
Figure 2
Risk of reintubation according to the studied population. Risk ratio of reintubation rate for the individual randomised controlled trials comparing steroids with control groups. Vertical line = 'no difference' point between the two groups; squares = risk ratios (the size of each square denotes the proportion of information given by each trial); diamonds = pooled risk ratios for randomised controlled trials that did not select patients at high risk (upper) and trials that did select patients at high risk, based on a reduced cuff-leak volume (CLV; lower); horizontal lines = 95% confidence intervals (CI).
Figure 3
Figure 3
Risk ratio for post-extubation stridor according to the studied population. Risk ratios of post-extubation stridor rate for the individual randomised controlled trials comparing steroids with control groups and the pooled analysis. Vertical line = 'no difference' point between the two groups; squares = risk ratios (the size of each square denotes the proportion of information given by each trial); diamonds = pooled odds ratios for randomised controlled trials that did not select patients at high risk (upper) and trials that did selected patients at high risk, based on a reduced cuff leak volume (CLV; lower); horizontal lines = 95% confidence intervals (CI).
Figure 4
Figure 4
Funnel plot for outcome reintubation to detect bias or systematic heterogeneity in trials according to the studied population (selected vs unselected patients at risk based on a reduced cuff-leak volume). Each point represents one trial. SE = Standard Error. RR = Relative Risk.
Figure 5
Figure 5
Risk for reintubation according to the steroid administration initiation timing before extubation in unselected patients. Risk ratios of reintubation rate for the individual randomised controlled trials comparing steroids with control groups and the pooled analysis. Vertical line = 'no difference' point between the two groups; squares = odds ratios (the size of each square denotes the proportion of information given by each trial); diamonds = pooled odds ratios for randomised controlled trials with for which steroid administration was started less than two hours before planned extubation (upper) and trials for which steroid administration was started at least four hours (ranged 4 to 24 hours) before planned extubation (lower); horizontal lines = 95% confidence intervals (CI). CLV = cuff-leak volume.
Figure 6
Figure 6
Risk for post-extubation stridor according to the timing steroid administration initiation before extubation in unselected patients. Risk ratios of post-extubation stridor rate for the individual randomised controlled trials comparing steroids with control groups and the pooled analysis. Vertical line = 'no difference' point between the two groups; squares = odds ratios (the size of each square denotes the proportion of information given by each trial); diamonds = pooled odds ratios for randomized controlled trials for which steroid administration was started less than two hours before planned extubation (upper) and trials for which steroid administration was started at least four hours (ranged 4 to 24 hours) before planned extubation (lower); horizontal lines = 95% confidence intervals (CI). CLV = cuff-leak volume.

References

    1. de Lassence A, Alberti C, Azoulay E, Le_Miere E, Cheval C, Vincent F, Cohen Y, Garrouste-Orgeas M, Adrie C, Troche G, Timsit JF, OUTCOMEREA Study Group Impact of unplanned extubation and reintubation after weaning on nosocomial pneumonia risk in the intensive care unit: a prospective multicenter study. Anesthesiology. 2002;97:148–156. doi: 10.1097/00000542-200207000-00021.
    1. Epstein SK, Ciubotaru RL. Independent effects of etiology of failure and time to reintubation on outcome for patients failing extubation. Am J Respir Crit Care Med. 1998;158:489–493.
    1. Epstein SK, Ciubotaru RL, Wong JB. Effect of failed extubation on the outcome of mechanical ventilation. Chest. 1997;112:186–192. doi: 10.1378/chest.112.1.186.
    1. Jaber S, Amraoui J, Lefrant J, Arich C, Cohendy R, Landreau L, Calvet Y, Capdevila X, Mahamat A, Eledjam J. Clinical practice and risk factors for immediate complications of endotracheal intubation in intensive care unit: a prospective multicenter study. Crit Care Med. 2006;34:2355–2361. doi: 10.1097/01.CCM.0000233879.58720.87.
    1. Jaber S, Chanques G, Matecki S, Ramonatxo M, Vergne C, Souche B, Perrigault PF, Eledjam JJ. Post-extubation stridor in intensive care unit patients. Risk factors evaluation and importance of the cuff-leak test. Intensive Care Med. 2003;29:69–74.
    1. Seymour CW, Martinez A, Christie JD, Fuchs BD. The outcome of extubation failure in a community hospital intensive care unit: a cohort study. Crit Care. 2004;8:R322–327. doi: 10.1186/cc2913.
    1. Torres A, Gatell J, Aznar E. Re-intubation increases the risk of nosocomial pneumonia in patients needing mechanical ventilation. Am J Respir Crit Care Med. 1995;152:137–141.
    1. Cheng KC, Chen CM, Tan CK, Lin SC, Chen HM, Zhang H. Methylprednisolone reduces the incidence of postextubation stridor associated with downregulation of IL-6 in critical ill patients. Am J Respir Crit Care Med. 2007. p. A593.
    1. Cheng KC, Hou CC, Huang HC, Lin SC, Zhang H. Intravenous injection of methylprednisolone reduces the incidence of postextubation stridor in intensive care unit patients. Crit Care Med. 2006;34:1345–1350. doi: 10.1097/.
    1. Darmon JY, Rauss A, Dreyfuss D, Bleichner G, Elkharrat D, Schlemmer B, Tenaillon A, Brun-Buisson C, Huet Y. Evaluation of risk factors for laryngeal edema after tracheal extubation in adults and its prevention by dexamethasone. A placebo-controlled, double-blind, multicenter study. Anesthesiology. 1992;77:245–251. doi: 10.1097/00000542-199208000-00004.
    1. Francois B, Bellissant E, Gissot V, Desachy A, Normand S, Boulain T, Brenet O, Preux PM, Vignon P. 12-h pretreatment with methylprednisolone versus placebo for prevention of postextubation laryngeal oedema: a randomised double-blind trial. Lancet. 2007;369:1083–1089. doi: 10.1016/S0140-6736(07)60526-1.
    1. Ho LI, Harn HJ, Lien TC, Hu PY, Wang JH. Postextubation laryngeal edema in adults. Risk factor evaluation and prevention by hydrocortisone. Intensive Care Med. 1996;22:933–936. doi: 10.1007/BF02044118.
    1. Lee CH, Peng MJ, Wu CL. Dexamethasone to prevent postextubation airway obstruction in adults: a prospective, randomized, double-blind, placebo-controlled study. Crit Care. 2007;11:R72. doi: 10.1186/cc5957.
    1. Shih CM, Chen W, Tu CY, Chen HJ, Lee JC, Tsai WK, Hsu WH. Multiple injections of hydrocortisone for the prevention of post-extubation stridor in acute respiratory failure. Am J Respir Crit Care Med. 2007. p. A593.
    1. Fan T, Wang G, Mao B, Xiong Z, Zhang Y, Liu X, Wang L, Yang S. Prophylactic administration of parenteral steroids for preventing airway complications after extubation in adults: meta-analysis of randomised placebo controlled trials. BMJ. 2008;337:a1841. doi: 10.1136/bmj.a1841.
    1. Markovitz BP, Randolph AG, Khemani RG. Corticosteroids for the prevention and treatment of postextubation stridor in neonates, children and adults. Cochrane Database Syst Rev. 2008:CD001000. 101002/14651858CD001000pub2.
    1. Marik PE, Pastores SM, Annane D, Meduri GU, Sprung CL, Arlt W, Keh D, Briegel J, Beishuizen A, Dimopoulou I, Tsagarakis S, Singer M, Chrousos GP, Zaloga G, Bokhari F, Vogeser M, American College of Critical Care Medicine Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med. 2008;36:1937–1949. doi: 10.1097/CCM.0b013e31817603ba.
    1. Prigent H, Maxime V, Annane D. Clinical review: corticotherapy in sepsis. Crit Care. 2004;8:122–129. doi: 10.1186/cc2374.
    1. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet. 1999;354:1896–1900. doi: 10.1016/S0140-6736(99)04149-5.
    1. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1–12. doi: 10.1016/0197-2456(95)00134-4.
    1. Greenland S, Robins JM. Estimation of a common effect parameter from sparse follow-up data. Biometrics. 1985;41:55–68. doi: 10.2307/2530643.
    1. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–1558. doi: 10.1002/sim.1186.
    1. VisualRx
    1. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634.
    1. Cucherat M, Boissel JP, Leizorovicz A, Haugh MC. EasyMA: a program for the meta-analysis of clinical trials. Comput Methods Programs Biomed. 1997;53:187–190. doi: 10.1016/S0169-2607(97)00016-3.
    1. Gaussorgues P, Boyer F, Piperno D, Gerard M, Leger P, Robert D. Laryngeal edema after extubation. Do corticosteroids play a role in its prevention? Presse Med. 1987;16:1531–1532.
    1. De Bast Y, De Backer D, Moraine J, Lemaire M, Vandenborght C, Vincent J. The cuff leak test to predict failure of tracheal extubation for laryngeal edema. Intensive Care Med. 2002;28:1267–1272. doi: 10.1007/s00134-002-1422-3.
    1. Miller R, Cole R. Association between reduced cuff leak volume and postextubation stridor. Chest. 1996;110:1035–1040. doi: 10.1378/chest.110.4.1035.
    1. Prinianakis G, Alexopoulou C, Mamidakis E, Kondili E, Georgopoulos D. Determinants of the cuff-leak test: a physiological study. Crit Care. 2005;9:R24–R31. doi: 10.1186/cc3012.
    1. Sandhu R, Pasquale M, Miller K, Wasser T. Measurement of endotracheal tube cuff leak to predict postextubation stridor and need for reintubation. J Am Coll Surg. 2000;190:682–687. doi: 10.1016/S1072-7515(00)00269-6.
    1. Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, Laterre PF, Reinhart K, Cuthbertson BH, Payen D, Briegel J, CORTICUS Study Group Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008;358:111–124. doi: 10.1056/NEJMoa071366.
    1. Kil H, Alberts M, Liggitt H, Bishop M. Dexamethasone treatment does not ameliorate subglottic ischemic injury in rabbits. Chest. 1997;111:1356–1360. doi: 10.1378/chest.111.5.1356.
    1. Kil HK, Kim WO, Koh SO. Effects of dexamethasone on laryngeal edema following short-term intubation. Yonsei Med J. 1995;36:515–520.
    1. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, Tugwell P, Klassen TP. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet. 1998;352:609–613. doi: 10.1016/S0140-6736(98)01085-X.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj